22ND CENTURY GROUP INC (XXII) Stock Price, Quote, News and Overview
NASDAQ:XXII - Nasdaq - US90137F3010 - Common Stock
XXII Quote and Key Statistics
22ND CENTURY GROUP INC
NASDAQ:XXII (1/22/2025, 2:09:46 PM)
5.07
-0.66 (-11.52%)
XXII Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -216.65% | ||
| ROE | -1633.47% | ||
| Debt/Equity | 1.59 |
XXII Performance and Technical Analysis
XXII Ownership and Analysts
XXII Latest News and Analysis
What's going on in today's session
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
These stocks are moving in today's session
Let's take a look at the stocks that are in motion in today's session.
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Stay updated with the stocks that are on the move in today's pre-market session.
Monday's pre-market session: top gainers and losers
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard
New FDA Rule Cites Extensive Research Using 22nd Century Manufactured Products and Specifically Cites 22nd Century VLN Sales Activity Proposed Standard...
About XXII
Company Profile
22nd Century Group Inc is a US-based company operating in Tobacco industry. The company is headquartered in Williamsville, New York and currently employs 64 full-time employees. The company went IPO on 2006-10-17. 22nd Century Group, Inc. is an agricultural biotechnology company. The firm is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The firm operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. The company uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.
Company Info
22ND CENTURY GROUP INC
8560 Main St Ste 4
Williamsville NEW YORK 14221 US
CEO: James A. Mish
Employees: 64
Company Website: https://www.xxiicentury.com/
Investor Relations: https://www.xxiicentury.com/investors
Phone: 17162701523
XXII Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PM | PHILIP MORRIS INTERNATIONAL | 19.3 | 190.81B | ||
| MO | ALTRIA GROUP INC | 10.12 | 86.09B | ||
| BTI | BRITISH AMERICAN TOB-SP ADR | 8.11 | 80.56B | ||
| RLX | RLX TECHNOLOGY INC-ADR | 18.79 | 3.54B | ||
| UVV | UNIVERSAL CORP/VA | 9.74 | 1.24B | ||
| TPB | TURNING POINT BRANDS INC | 16.97 | 1.01B | ||
| ISPR | ISPIRE TECHNOLOGY INC | N/A | 252.66M |